Sleep apnea device put to the test in heavier, more severe patients

NCT ID NCT07113288

Recruiting now Disease control Sponsor: Inspire Medical Systems, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a device called Inspire, which is implanted in the body to treat obstructive sleep apnea. It is being studied in people with more severe sleep apnea (higher AHI) and higher body weight (higher BMI) who cannot use CPAP machines. The study will follow 70 participants over time to see if the device is safe and helps improve their breathing during sleep.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Inspire® UAS System (implantable device)
What this could lead to: If successful, this could expand the use of the Inspire device to more people with severe sleep apnea and higher body weight, offering an alternative to CPAP machines.
What could go wrong: This is an observational study, not a randomized trial, so results may be less definitive. The device requires surgery and may have side effects like discomfort or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBSTRUCTIVE SLEEP APNEA (OSA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

obstructive sleep apnea syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBSTRUCTIVE SLEEP APNEA (OSA)

Contacts and locations

Locations

Colorado ENT & Allergy
RECRUITING

Colorado Springs, Colorado, 80923, United States
Florida Sleep Specialists
RECRUITING

Bradenton, Florida, 34209, United States
Rush University Medical Center
RECRUITING

Chicago, Illinois, 60612, United States
University of Kansas Medical Center
RECRUITING

Kansas City, Kansas, 66160, United States
University of Rochester
RECRUITING

Rochester, New York, 14642, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.